The one and only brand to successfully make NADH bioavailable for the human body.
Austrian scientist, Prof. George Birkmayer, MD, PhD (*1941-2022†) was the leading expert in NADH research. In 1987, he discovered the therapeutic effects of NADH. He was the first to succeed in stabilizing NADH in tablet form and making it bioavailable for the human body. He received worldwide recognition and over 50 patents for this monumental formulation. This breakthrough approach allowed his team of scientists to perform numerous clinical studies to prove NADH’s beneficial effects for Alzheimer’s and Parkinson’s Disease, Chronic Fatigue Syndrome (CFS), depression, aging, and sleep deprivation. Birkmayer NADH offers the one and only NADH, the efficacy of which has been substantiated by numerous scientific studies. Birkmayer NADH was founded first in Austria in 2013 and then in the United States in 2018. They have their own lab and perform constant quality testing.
To put it simply: Cellular Energy = Life. Nicotinamide adenine dinucleotide (NADH) is naturally occurring in every living cell. As NADH reacts with oxygen it produces ATP which is used for ALL function. In a nutshell. The more ATP a cell has, the longer we live. Since it declines as we age, taking this supplement can be profound.
NADH by Professor Birkmayer is one of my top 3 supplements offered in the DW Shop. This is, by definition, cutting edge science (with just the right splash of magic).
Get exclusive access to new formulas, brand launches, just-for-our-community sale events, and more.